Psychopharmacologic management during cancer treatment Journal Article
| Authors: | Joshi, N.; Breitbart, W. S. |
| Article Title: | Psychopharmacologic management during cancer treatment |
| Abstract: | The patient with cancer faces many stressors during the course of the illness, including fears of death, disability, disfigurement, dependency, and abandonment, as well as disruptions in relationships, role functioning, and financial status. Although such concerns are universal, the level of psychological distress varies depending on psychologic, medical, and social factors. As people are becoming more optimistic about cancer survival as a result of improved cancer treatments, patients and their families are more interested in quality-of-life issues, including psychologic well-being and treatment of psychiatric issues, during and after cancer treatment. In this article, we discuss the psychopharmacologic management of the commonly seen psychiatric syndromes of anxiety, depression and delirium during cancer treatment. © 2003 Elsevier Inc. All rights reserved. |
| Keywords: | disease course; drowsiness; neutropenia; review; dose response; drug safety; side effect; antineoplastic agent; anorexia; neoplasms; unindexed drug; low drug dose; liver toxicity; heart disease; nausea; vomiting; chlorpromazine; lorazepam; midazolam; opiate; delirium; sedation; drug effect; asthenia; confusion; insomnia; depression; sexual dysfunction; cardiovascular disease; carcinoma; neuroleptic agent; anxiety disorder; mental disease; psychotropic drugs; mirtazapine; seizure; anxiety; headache; drug metabolism; drug half life; respiration depression; somnolence; motor dysfunction; psychosis; alprazolam; venlafaxine; gastrointestinal disease; citalopram; clonazepam; fluoxetine; paroxetine; sertraline; liver injury; analgesic agent; antihistaminic agent; agitation; tricyclic antidepressant agent; amfebutamone; psychostimulant agent; serotonin uptake inhibitor; weight gain; motor coordination; trazodone; priapism; hydroxyzine; diazepam; restlessness; nefazodone; liver metabolism; humans; human; temazepam; thioridazine; chlordiazepoxide; clorazepate; oxazepam; retrograde amnesia |
| Journal Title: | Seminars in Clinical Neuropsychiatry |
| Volume: | 8 |
| Issue: | 4 |
| ISSN: | 1084-3612 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2003-10-01 |
| Start Page: | 241 |
| End Page: | 252 |
| Language: | English |
| PUBMED: | 14613051 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Export Date: 25 September 2014 -- Source: Scopus |
Citation Impact
Related MSK Work